Journal article icon

Journal article

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.

Abstract:

OBJECTIVE: To investigate the long-term antidiabetogenic effect of glucagon-like peptide 1 (GLP-1) and its influence on diabetic dyslipoproteinemia, patients with NIDDM were treated with GLP-1 subcutaneously for 1 week. RESEARCH DESIGN AND METHODS: Twelve patients participated in the study. The 1st week of the study, all of them were on intensive insulin treatment and from day 8, four were randomized to a control group continuing with insulin, and eight to a treatment group where GLP-1 was gi...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2337/diacare.19.11.1200

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author
Expand authors...
Journal:
Diabetes care
Volume:
19
Issue:
11
Pages:
1200-1206
Publication date:
1996-11-01
DOI:
EISSN:
1935-5548
ISSN:
0149-5992
Source identifiers:
12722

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP